CN100532548C - 一种提高人乳头瘤病毒l1蛋白原核表达产率的方法 - Google Patents
一种提高人乳头瘤病毒l1蛋白原核表达产率的方法 Download PDFInfo
- Publication number
- CN100532548C CN100532548C CNB2007100051003A CN200710005100A CN100532548C CN 100532548 C CN100532548 C CN 100532548C CN B2007100051003 A CNB2007100051003 A CN B2007100051003A CN 200710005100 A CN200710005100 A CN 200710005100A CN 100532548 C CN100532548 C CN 100532548C
- Authority
- CN
- China
- Prior art keywords
- hpv
- sequence
- proteic
- albumen
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
HPV型 | 密码子优化序列表达得到的L1蛋白占总蛋白的百分比(%) | 未经密码子优化的序列表达得到的L1蛋白占总蛋白的百分比(%) |
HPV6 | 22.3 | 6.1 |
HPV11 | 21.1 | 7.2 |
HPV18 | 19.8 | 6.5 |
HPV31 | 24.6 | 7.9 |
HPV33 | 26.9 | 8.1 |
HPV35 | 22.0 | 6.6 |
HPV39 | 22.4 | 5.8 |
HPV45 | 20.7 | 7.8 |
HPV 51 | 26.6 | 8.5 |
HPV 52 | 20.8 | 5.7 |
HPV 56 | 23.7 | 6.3 |
HPV58 | 24.5 | 6.7 |
HPV 59 | 22.3 | 7.2 |
HPV 68 | 22.5 | 6.9 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100051003A CN100532548C (zh) | 2007-02-14 | 2007-02-14 | 一种提高人乳头瘤病毒l1蛋白原核表达产率的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100051003A CN100532548C (zh) | 2007-02-14 | 2007-02-14 | 一种提高人乳头瘤病毒l1蛋白原核表达产率的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101016542A CN101016542A (zh) | 2007-08-15 |
CN100532548C true CN100532548C (zh) | 2009-08-26 |
Family
ID=38725763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2007100051003A Active CN100532548C (zh) | 2007-02-14 | 2007-02-14 | 一种提高人乳头瘤病毒l1蛋白原核表达产率的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100532548C (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1398927B1 (it) * | 2009-06-25 | 2013-03-28 | Consorzio Interuniversitario Per Lo Sviluppo Dei Sistemi A Grande Interfase Csgi | Espressione batterica di un gene artificiale per la produzione di crm197 e derivati. |
CN105177025B (zh) * | 2013-12-03 | 2022-11-01 | 北京康乐卫士生物技术股份有限公司 | 18型重组人乳头瘤病毒病毒样颗粒及其制备方法 |
CN104761623B (zh) * | 2013-12-17 | 2019-11-29 | 北京康乐卫士生物技术股份有限公司 | 一种以α-螺旋5为靶标的抑制HPV L1五聚体形成的抑制剂 |
CN103740728B (zh) * | 2013-12-30 | 2016-08-17 | 中国人民武装警察部队后勤学院 | 稀有密码子改造的人znf580基因及该基因原核表达的蛋白及多克隆抗体 |
CN105713087B (zh) * | 2014-11-12 | 2020-05-08 | 北京康乐卫士生物技术股份有限公司 | 人乳头瘤病毒58型单克隆抗体及其应用 |
CN105585631B (zh) * | 2014-11-12 | 2020-08-18 | 北京康乐卫士生物技术股份有限公司 | 人乳头瘤病毒16型单克隆抗体及其应用 |
CN106701798B (zh) * | 2015-08-12 | 2021-09-17 | 北京康乐卫士生物技术股份有限公司 | 45型重组人乳头瘤病毒病毒样颗粒及其制备方法 |
CN106701796B (zh) * | 2015-08-12 | 2021-11-16 | 北京康乐卫士生物技术股份有限公司 | 52型重组人乳头瘤病毒病毒样颗粒及其制备方法 |
CN106701797B (zh) * | 2015-08-12 | 2021-06-15 | 北京康乐卫士生物技术股份有限公司 | 31型重组人乳头瘤病毒病毒样颗粒及其制备方法 |
CN106399329B (zh) * | 2015-08-12 | 2021-06-11 | 北京康乐卫士生物技术股份有限公司 | 33型重组人乳头瘤病毒病毒样颗粒及其制备方法 |
CN113073105B (zh) * | 2021-03-23 | 2023-06-13 | 重庆博唯佰泰生物制药有限公司 | 一种表达hpv 56l1的多核苷酸序列及其表达载体、宿主细胞和应用 |
CN116023446A (zh) * | 2022-10-28 | 2023-04-28 | 北京康乐卫士生物技术股份有限公司 | 人乳头瘤病毒hpv68 l1蛋白的表达和类病毒样颗粒及其制备方法 |
CN115960178B (zh) * | 2022-12-28 | 2023-09-08 | 北京康乐卫士生物技术股份有限公司 | 人乳头瘤病毒hpv59 l1蛋白的表达和类病毒样颗粒及其制备方法 |
CN117054647A (zh) * | 2023-07-17 | 2023-11-14 | 广东省一鼎生物技术有限公司 | 一种检测HPV IgG抗体试剂盒及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005123762A2 (en) * | 2004-06-18 | 2005-12-29 | Indian Immunologicals Ltd | Codon-optimized hpv16 li for salmonella vaccine strains against human papillomavirus type 16 |
-
2007
- 2007-02-14 CN CNB2007100051003A patent/CN100532548C/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005123762A2 (en) * | 2004-06-18 | 2005-12-29 | Indian Immunologicals Ltd | Codon-optimized hpv16 li for salmonella vaccine strains against human papillomavirus type 16 |
Also Published As
Publication number | Publication date |
---|---|
CN101016542A (zh) | 2007-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100532548C (zh) | 一种提高人乳头瘤病毒l1蛋白原核表达产率的方法 | |
CN101245099A (zh) | 重组人乳头瘤病毒l1衣壳蛋白的氨基酸序列及其应用 | |
CN1942583B (zh) | Hpv58l1在酵母中的最优化表达 | |
US7700103B2 (en) | Optimized expression of HPV 52 L1 in yeast | |
US7482015B2 (en) | Optimized expression of HPV 45 L1 in yeast | |
CN100506999C (zh) | Hpv31l1在酵母中的优化表达 | |
CN101481408A (zh) | 防止高度聚合的重组人乳头瘤病毒l1蛋白的修饰序列 | |
CN101481407A (zh) | 重组人乳头瘤病毒l1衣壳蛋白的修饰序列 | |
CN114127098B (zh) | 嵌合的人乳头瘤病毒51型l1蛋白 | |
WO2021013073A1 (zh) | 嵌合的乳头瘤病毒l1蛋白 | |
CN1293093C (zh) | 乳头瘤病毒衣壳蛋白的原核制备和应用 | |
CN114127100B (zh) | 嵌合的人乳头瘤病毒39型l1蛋白 | |
CN103992395A (zh) | 重组hpv-58型l1的vlp疫苗及其制备方法 | |
CN103819543A (zh) | 重组的人乳头瘤病毒6型l1蛋白及其用途 | |
CN114127127B (zh) | 嵌合的人乳头瘤病毒35型l1蛋白 | |
CN114127095B (zh) | 嵌合的人乳头瘤病毒11型l1蛋白 | |
CN114127094B (zh) | 嵌合的人乳头瘤病毒58型l1蛋白 | |
WO2021013067A1 (zh) | 嵌合的人乳头瘤病毒6型l1蛋白 | |
CN104045696A (zh) | 重组的人乳头瘤病毒16型l1蛋白及其用途 | |
WO2021013062A1 (zh) | 嵌合的人乳头瘤病毒31型l1蛋白 | |
WO2021013079A1 (zh) | 嵌合的人乳头瘤病毒56型l1蛋白 | |
CN104045695A (zh) | 重组的人乳头瘤病毒18型l1蛋白及其用途 | |
MXPA06005306A (en) | Optimized expression of hpv 58 l1 in yeast |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING HEALTHY GUARD BIOTECHNOLOGY INC. Free format text: FORMER OWNER: MA RUNLIN Effective date: 20130312 Free format text: FORMER OWNER: CHEN XIAOJIANG Effective date: 20130312 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100107 CHAOYANG, BEIJING TO: 100176 DAXING, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130312 Address after: Longsheng industrial park, 7 No. 100176 Beijing Rongchang economic and Technological Development Zone Street No. 2 building 201 unit Patentee after: Beijing Healthy Guard Biotechnology Inc. Address before: 100107 Beijing city Chaoyang District Wankexingyuan 9 room No. 1505 Patentee before: Ma Runlin Patentee before: Chen Xiaojiang |
|
DD01 | Delivery of document by public notice |
Addressee: Ma Runlin Document name: Notification of Passing Examination on Formalities |
|
C56 | Change in the name or address of the patentee |
Owner name: BEIJING HEALTH GUARD BIOTECHNOLOGY CO., LTD. Free format text: FORMER NAME: BEIJING HEALTHY GUARD BIOTECHNOLOGY INC. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Longsheng industrial park, 7 No. 100176 Beijing Rongchang economic and Technological Development Zone Street No. 2 building 201 unit Patentee after: Beijing Health Guard Biotechnology Co., Ltd. Address before: Longsheng industrial park, 7 No. 100176 Beijing Rongchang economic and Technological Development Zone Street No. 2 building 201 unit Patentee before: Beijing Healthy Guard Biotechnology Inc. |
|
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Ma Runlin Inventor after: Chen Xiaojiang Inventor after: Liu Yongjiang Inventor before: Ma Runlin Inventor before: Chen Xiaojiang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: MA RUNLIN CHEN XIAOJIANG TO: MA RUNLIN CHEN XIAOJIANG LIU YONGJIANG |